Novartis, Gilead in joint financing of personalized medicine platform 06-Feb-2020 By Vassia Barba Vineti’s latest financing round sees Novartis and Gilead join forces to invest in technology platform that enables scale-up of CAR Ts and allogeneic cell therapies.
Vineti, Cryoport partner to extend end-to-end cell therapy logistics offering 10-Sep-2019 By Vassia Barba A collaboration between Vineti and Cryoport aims to extend supply chain services as the cell and gene therapies space continues to scale.